surgical manipulation, defibrillation threshold testing and at the same time there should be quick recovery after the procedure. 2 Conscious sedation though appears simple, it is one of the most challenging areas in emerging trends in anaesthesiology. It describes a well sedated patient who should remain quiet for two to three hours during the procedure, should respond to verbal comands whenever required and at the same time should not go into deep sleep, respiratory depression or have haemodynamic instability. The objective of this study was to evaluate the safety, efficacy and feasibility of placing AICD in the cardiac catheterization laboratory using conscious sedation.
Methods:
Patients: Ten patients of either sex (9 males, 1 female) in the age range of 35 to 65 years weighing 50-60 kg were subjected to the study. Eight patients had syncopal ventricular tachycardia as the indication for implanting cardioverter defibrillator. The remaining two had sustained episodes of haemodynamically unstable ventricular tachycardia. Complete cardiology workup including echocardiography, coronary angiography was performed in all patients. Seven patients had the diagnosis of ischaemic dilated cardiomyopathy, two of them had dilated cardiomyopathy of nonischaemic origin and one had obstructive cardiomyopathy. Most of the patients were receiving ventricular arrhythmia prophylaxis with amiodarone along with other supportive medical treatment. All of the patients received antibiotic prophylaxis of Ceftriaxone 1gm I/v once daily on the day before the procedure.
Pre-anaesthetic check-up was done by the cardiac anaesthesiologist the day before the procedure and assessed for cardiorespiratory status and associated medical diseases. Ejection fraction was in the range of 25-30% with New York Heart Association (NYHA) class between 2-3. Suitability from the point of view of general anaesthesia were also assessed. They were accepted in American Society of Anaesthesiologists (ASA) grade 3. Informed consent was obtained for the procedure both for conscious sedation and general anaesthesia.
Procedure:
Following informed consent patients were brought to the cardiac catheterization laboratory after an overnight fast. After establishment of intravenous line, patients were connected to electrocardiogram for continuous monitoring of heart rate and rhythm and arterial oxygen saturation by pulse oximeter. Patch electrodes were fixed in the anterior and posterior positions on the left side of the chest and were connected to automatic external defibrillator. During induction of ventricular fibrillation, it was kept in the manual mode so that in case defibrillation by the device failed, it could be activated and the desired energy could be used to defibrillate the heart. Under local anaesthesia, right femoral vein was punctured and temporary pacemaker was kept in VVI mode with pacing rate 40-50/min. The conscious sedation was initiated at this stage with an Intravenous injection of midazolam 1mg and fentanyl citrate 50 µgm .The time of starting conscious sedation was noted. The degree of sedation was monitored by the Ramsay Sedation Scale 3 . Fentanyl Citrate 25-50 µgm was repeated when required to achieve conscious sedation upto level 4 of Ramsay Sedation Scale. 5-6 L/min of oxygen by face mask was administered to maintain arterial oxygen saturation of 99-100%. Under local anaesthesia (2% plain lignocane 10-12 ml) incision and making subcutaneous pocket and insertion of defibrillation lead through left subclavian vein in the left infraclavicular region was done. The leads were finally positioned in the right ventricular apex under fluoroscopic guidance. After appropriate sensing and pacing the ventricular lead was secured to the pectoral fascia. Five minutes before defibrillation threshold testing another dose of fentanyl citrate 25µgm and propofol in the bolus dose of 0 . 4-0 . 5µgm/kg was given to keep the patient in a state of deep sedation (level 5 of Ramsay sedation scale). Ventricular fibrillation was induced with high energy stimulus DC shock 12 J for 2 seconds and automatic defibrillation capability of the device was tested with 15-20 J.Finally the device was activated for detection of ventricular fibrillation and automatic defibrillation based on morphology discrimation before the patient was shifted to the coronary care unit. Patients were monitored continuously for heart rate, blood pressure (non-invasive), arterial oxygen saturation, level of sedation and apnoea. After full recovery from sedation, patients were questioned to assess the degree of amnesia for operative and post-operative events and overall satisfaction with the technique.
Results:
In our protocol midazolam was used as a basal sedative supplemented with a short acting opioidfentanyl citrate and propofol. The total dose of midazolam was 1mg, fetanyl 100-150 µgm and propofol 0 . 4-0 . 5mg/kg. The sedation time was 60±30 mins. Patients remained relaxed and haemodynamically stable. None of the patients had respiratory depression, apnoea,decrease in oxygen saturation below 96% and all the patients were cooperative during the procedure. Patient may progress from one degree of sedation to another depending on the underlying medical status, the medications administered, dosage and route of administration. In cardiac patients, the response to sedatives may vary due to altered brain circulation time and pharmacodynamics. Genotype may influence perioperative risk and outcome. 5 Various drugs that have been used singly or in combination for conscious sedation include: midazolam, fentanil, morphine,propofol,chloral hydrate, droperidol and pethidine. Morphine has been popular but there is always a possibility of deep sedation or respiratory depression. With the availability of short acting benzodiazepines and opioids, technique of conscious sedation has become safer. Propofol can offer an additional advantage due to its short duration of action, fast recovery and anti-emetic properties. Propofol in the bolous dose of 400 µg/kg has been used for defibrillation threshold testing. However it may cause dose dependent fall in blood pressure and apnoea. Propofol infusion in the dose of 20-50 µg/kg/min can be used safely for maintaining conscious sedation. Thiopentone has also been used for the same purpose but prolonged recovery is observed with thiopentone. 6 With general anaesthesia, there is obviously optimum patient comfort and better airway control but some cardiorespiratory complications in cardiac patients with poor left ventricular functions can not be ruled out. Some of the recent reports have shown 4 percent complication rate directly related to endotracheal intubation and general anaesthesia. 7 Moreover there may be prolonged hospital stay in those who receive general anaesthesia. 8 The patient ' s in this series underwent nonthoracotomy placement of automatic ICD under conscious sedation without general anaesthesia. The technique of conscious sedation used was found to be safe and ideally suited for this procedure.
In our protocol of conscious sedation we used midazolam, propofol and fentanyl with no obvious complications except one who required external defibrillation with patch electrode for defibrillation testing (DFT). Pacifio and his associates from Houston,Texas used midazolam 15-30 µg/kg within 20 seconds, promethazine 180-360 µg/kg and morphine 30-90 µg/kg for conscious sedation. To induce deep sedation for defibrillation testing, a bolus of etomidate 80-120 µg/kg within 20 seconds was administered. 9 VP Singh and his associates from Army Hospital Delhi, India developed a protocol for initiation of conscious sedation with an IV injection of midazolam 1mg and fentanyl citrate 50 µg and when required midazolam 0.5 to 1mg and fentanyl citrate 25-50 µg was repeated as and when required to achieve conscious sedation level up to level 4 of Ramsay sedation scale. Some workers have used another protocol with midazolam 15 to 30 µg/kg followed by propofol infusion in the dose of 20-50 µg/kg/min. During DFT s, propofol bolus in the dose of 400-500 µg/kg was administered. Tung et al have used midazolam 1-2 mg or fentanyl 25-50 µg or both every 2-5 min depending upon the depth of sedation, which was monitored closely for respiratory pattern, eyelash reflex and spontaneous movements to painful stimuli 10 . The dose of midazolam and fentanyl ranged between 2-4 mg and 150-300 µg respectively . On follow up, none of their patients recalled pain or shock during the procedure except one, who recalled 1 of 5 shocks during implantation.
We assessed recovery of our patients by applying Ramsay sedation scale . All patients achieved the scale of 2-3 within 15-30 min following conscious sedation.The recovery charecteristics can also be monitored by applying the Aldrete scoring system. There were no cardiac or respiratory complications due to conscious sedation in any of our patients either during or after the procedure. The brief twitching movements in two patients in whom the defibrillation testing by the device failed, could be due to delay in the charging in the capacitor.With the increasing number of implantations of ICDs, the anaesthesiologists will have greater role to play in the cardiac catheterization / electrophysiological laboratory. The results of our technique of conscious sedation suggest that it is safe, reliable and with no major compromise of cardiorespiratory function.
